CBD for Epilepsy Information

This CBD for Epilepsy information in this video is by Tanja Bagar, PhD, she is the founder and CEO of the International Institute for Cannabinoids based out of Slovenia. Tanja has spent the last several years studying and teaching about cannabinoids throughout Europe.

This conversation in her video talks about her experience in discovering the therapeutic potential of cannabinoids. Also how Cannabis regulations vary throughout Europe. She also talks about becoming fascinated with the endocannabinoid system, clinical outcomes in patients using cannabinoids through ICANNA and what she thinks about the future of Cannabis research.

You can visit ICANNA here https://www.institut-icanna.com/en/index.html

If you or somebody you know has been diagnosed with epilepsy, then you have probably heard of the many benefits of CBD for epilepsy from researchers. Epilepsy is a condition where seizures happen unexpectedly. This can be both a mental and physical struggle. It is also known as “spike” because sometimes the patient will actually have an attack, which causes the person to have an extremely high rise in heart rate and blood pressure.

Along with helping epilepsy it may also have the ability to relieve depression, anxiety and tension that may come along with it. Of course you will want to talk this over with your physician.

CBD Effective in Reducing Seizures In Some

The epilepsy foundation  (https://www.epilepsy.com/)  says “Cannabidiol, or CBD, which does not cause psychoactive effects but has shown some positive effects on certain body systems. This is the part that has been effective in reducing seizures in some people with epilepsy.”

What is Tanja Bagar PhD’s perspective on using CBD for epilepsy?

Tanja Bagar PhD holds an intriguing perspective on cbd and epilepsy treatment options. As a renowned expert in the field, her insights shed light on the potential benefits CBD may offer for individuals with epilepsy. Her research and expertise contribute valuable insights to the ongoing discussion surrounding the use of CBD as a potential treatment option for epilepsy.

Does cannabis help seizures?

Over several years there have been small clinical studies that suggest CBD could potentially help control ones seizures epilepsy.com states.

They have also said that research on CBD for epilepsy has taken time because of its regulation and limited access to cannibidiol. In recent years, several studies have shown the benefits of specific CBD products in treating certain groups of epileptic people that have not responded to traditional therapies.

Remember that not all CBD products are created equal. Remember to talk to your doctor about the benefit potential and the possible interaction with other seizure medications. Possible side effects need careful review with you and your doctor.

What are the Benefits of CBD for Epilepsy?

CBD, or cannabidiol, has gained attention for its potential in treating epilepsy. Research suggests that treating epilepsy with cbd can help reduce the frequency and severity of seizures. CBD interacts with the body’s endocannabinoid system to regulate seizure activity. Additionally, CBD is known for its anti-inflammatory and neuroprotective properties, which may contribute to its potential benefits for epilepsy. While more studies are needed, CBD shows promising potential as an alternative treatment option for individuals with epilepsy.

Studies That Support The Use Of CBD for Epilepsy

Data from these studies has helped provide evidence that led to the FDA approval of this product on June 25, 2018. The NEJM ( https://www.nejm.org/doi/10.1056/NEJMoa1714631) showed that Epidiolex CBD extract, a pharmacuetical had these results: “Among children and adults with the Lennox–Gastaut syndrome, the addition of cannabidiol at a dose of 10 mg or 20 mg per kilogram per day to a conventional antiepileptic regimen resulted in greater reductions in the frequency of drop seizures than placebo. Adverse events with cannabidiol included elevated liver aminotransferase concentrations. (Funded by GW Pharmaceuticals; GWPCARE3 ClinicalTrials.gov number, NCT02224560.)”.

You can read more about these clinical trials here https://www.nejm.org/doi/10.1056/NEJMoa1714631.